Global Monoclonal Antibody Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 119674
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Monoclonal Antibody Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Monoclonal Antibody Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Monoclonal Antibody Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cancer segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Monoclonal Antibody Treatment include Pfizer, Bayer, Sanofi, Merck, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Monoclonal Antibody Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Cancer

Autoimmune Diseases

Exogenous Infection

Hematological Diseases

Market segment by Application, can be divided into

Hospitals

Clinics

Others

Market segment by players, this report covers

Pfizer

Bayer

Sanofi

Merck

GlaxoSmithKline

Roche

Novartis

AbbVie

Shanghai Junshi Biosciences Co.,Ltd

Innovent Biologics

Jiangsu Hengrui Medicine Co.,Ltd.

BeiGene, Ltd.

Grand Pharmaceutical (China) Co., Ltd

Henlius

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Monoclonal Antibody Treatment product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Monoclonal Antibody Treatment, with revenue, gross margin and global market share of Monoclonal Antibody Treatment from 2019 to 2022.

Chapter 3, the Monoclonal Antibody Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Monoclonal Antibody Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Monoclonal Antibody Treatment research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Monoclonal Antibody Treatment

1.2 Classification of Monoclonal Antibody Treatment by Type

1.2.1 Overview: Global Monoclonal Antibody Treatment Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Monoclonal Antibody Treatment Revenue Market Share by Type in 2021

1.2.3 Cancer

1.2.4 Autoimmune Diseases

1.2.5 Exogenous Infection

1.2.6 Hematological Diseases

1.3 Global Monoclonal Antibody Treatment Market by Application

1.3.1 Overview: Global Monoclonal Antibody Treatment Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Monoclonal Antibody Treatment Market Size & Forecast

1.5 Global Monoclonal Antibody Treatment Market Size and Forecast by Region

1.5.1 Global Monoclonal Antibody Treatment Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Monoclonal Antibody Treatment Market Size by Region, (2017-2022)

1.5.3 North America Monoclonal Antibody Treatment Market Size and Prospect (2017-2028)

1.5.4 Europe Monoclonal Antibody Treatment Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Monoclonal Antibody Treatment Market Size and Prospect (2017-2028)

1.5.6 South America Monoclonal Antibody Treatment Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Monoclonal Antibody Treatment Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Monoclonal Antibody Treatment Market Drivers

1.6.2 Monoclonal Antibody Treatment Market Restraints

1.6.3 Monoclonal Antibody Treatment Trends Analysis

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Monoclonal Antibody Treatment Product and Solutions

2.1.4 Pfizer Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Bayer

2.2.1 Bayer Details

2.2.2 Bayer Major Business

2.2.3 Bayer Monoclonal Antibody Treatment Product and Solutions

2.2.4 Bayer Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Bayer Recent Developments and Future Plans

2.3 Sanofi

2.3.1 Sanofi Details

2.3.2 Sanofi Major Business

2.3.3 Sanofi Monoclonal Antibody Treatment Product and Solutions

2.3.4 Sanofi Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Sanofi Recent Developments and Future Plans

2.4 Merck

2.4.1 Merck Details

2.4.2 Merck Major Business

2.4.3 Merck Monoclonal Antibody Treatment Product and Solutions

2.4.4 Merck Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Merck Recent Developments and Future Plans

2.5 GlaxoSmithKline

2.5.1 GlaxoSmithKline Details

2.5.2 GlaxoSmithKline Major Business

2.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Product and Solutions

2.5.4 GlaxoSmithKline Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 GlaxoSmithKline Recent Developments and Future Plans

2.6 Roche

2.6.1 Roche Details

2.6.2 Roche Major Business

2.6.3 Roche Monoclonal Antibody Treatment Product and Solutions

2.6.4 Roche Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Roche Recent Developments and Future Plans

2.7 Novartis

2.7.1 Novartis Details

2.7.2 Novartis Major Business

2.7.3 Novartis Monoclonal Antibody Treatment Product and Solutions

2.7.4 Novartis Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Novartis Recent Developments and Future Plans

2.8 AbbVie

2.8.1 AbbVie Details

2.8.2 AbbVie Major Business

2.8.3 AbbVie Monoclonal Antibody Treatment Product and Solutions

2.8.4 AbbVie Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 AbbVie Recent Developments and Future Plans

2.9 Shanghai Junshi Biosciences Co.,Ltd

2.9.1 Shanghai Junshi Biosciences Co.,Ltd Details

2.9.2 Shanghai Junshi Biosciences Co.,Ltd Major Business

2.9.3 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Product and Solutions

2.9.4 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Shanghai Junshi Biosciences Co.,Ltd Recent Developments and Future Plans

2.10 Innovent Biologics

2.10.1 Innovent Biologics Details

2.10.2 Innovent Biologics Major Business

2.10.3 Innovent Biologics Monoclonal Antibody Treatment Product and Solutions

2.10.4 Innovent Biologics Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Innovent Biologics Recent Developments and Future Plans

2.11 Jiangsu Hengrui Medicine Co.,Ltd.

2.11.1 Jiangsu Hengrui Medicine Co.,Ltd. Details

2.11.2 Jiangsu Hengrui Medicine Co.,Ltd. Major Business

2.11.3 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Product and Solutions

2.11.4 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments and Future Plans

2.12 BeiGene, Ltd.

2.12.1 BeiGene, Ltd. Details

2.12.2 BeiGene, Ltd. Major Business

2.12.3 BeiGene, Ltd. Monoclonal Antibody Treatment Product and Solutions

2.12.4 BeiGene, Ltd. Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 BeiGene, Ltd. Recent Developments and Future Plans

2.13 Grand Pharmaceutical (China) Co., Ltd

2.13.1 Grand Pharmaceutical (China) Co., Ltd Details

2.13.2 Grand Pharmaceutical (China) Co., Ltd Major Business

2.13.3 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Product and Solutions

2.13.4 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Grand Pharmaceutical (China) Co., Ltd Recent Developments and Future Plans

2.14 Henlius

2.14.1 Henlius Details

2.14.2 Henlius Major Business

2.14.3 Henlius Monoclonal Antibody Treatment Product and Solutions

2.14.4 Henlius Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Henlius Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Monoclonal Antibody Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Monoclonal Antibody Treatment Players Market Share in 2021

3.2.2 Top 10 Monoclonal Antibody Treatment Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Monoclonal Antibody Treatment Players Head Office, Products and Services Provided

3.4 Monoclonal Antibody Treatment Mergers & Acquisitions

3.5 Monoclonal Antibody Treatment New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Monoclonal Antibody Treatment Revenue and Market Share by Type (2017-2022)

4.2 Global Monoclonal Antibody Treatment Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Monoclonal Antibody Treatment Revenue Market Share by Application (2017-2022)

5.2 Global Monoclonal Antibody Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Monoclonal Antibody Treatment Revenue by Type (2017-2028)

6.2 North America Monoclonal Antibody Treatment Revenue by Application (2017-2028)

6.3 North America Monoclonal Antibody Treatment Market Size by Country

6.3.1 North America Monoclonal Antibody Treatment Revenue by Country (2017-2028)

6.3.2 United States Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

6.3.3 Canada Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

6.3.4 Mexico Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Monoclonal Antibody Treatment Revenue by Type (2017-2028)

7.2 Europe Monoclonal Antibody Treatment Revenue by Application (2017-2028)

7.3 Europe Monoclonal Antibody Treatment Market Size by Country

7.3.1 Europe Monoclonal Antibody Treatment Revenue by Country (2017-2028)

7.3.2 Germany Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

7.3.3 France Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

7.3.5 Russia Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

7.3.6 Italy Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Monoclonal Antibody Treatment Revenue by Type (2017-2028)

8.2 Asia-Pacific Monoclonal Antibody Treatment Revenue by Application (2017-2028)

8.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region

8.3.1 Asia-Pacific Monoclonal Antibody Treatment Revenue by Region (2017-2028)

8.3.2 China Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

8.3.3 Japan Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

8.3.4 South Korea Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

8.3.5 India Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

8.3.7 Australia Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Monoclonal Antibody Treatment Revenue by Type (2017-2028)

9.2 South America Monoclonal Antibody Treatment Revenue by Application (2017-2028)

9.3 South America Monoclonal Antibody Treatment Market Size by Country

9.3.1 South America Monoclonal Antibody Treatment Revenue by Country (2017-2028)

9.3.2 Brazil Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

9.3.3 Argentina Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Monoclonal Antibody Treatment Revenue by Type (2017-2028)

10.2 Middle East & Africa Monoclonal Antibody Treatment Revenue by Application (2017-2028)

10.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country

10.3.1 Middle East & Africa Monoclonal Antibody Treatment Revenue by Country (2017-2028)

10.3.2 Turkey Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

10.3.4 UAE Monoclonal Antibody Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Monoclonal Antibody Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Monoclonal Antibody Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Monoclonal Antibody Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Monoclonal Antibody Treatment Revenue (USD Million) by Region (2017-2022)

Table 5. Global Monoclonal Antibody Treatment Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Monoclonal Antibody Treatment Product and Solutions

Table 9. Pfizer Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Bayer Corporate Information, Head Office, and Major Competitors

Table 11. Bayer Major Business

Table 12. Bayer Monoclonal Antibody Treatment Product and Solutions

Table 13. Bayer Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Sanofi Corporate Information, Head Office, and Major Competitors

Table 15. Sanofi Major Business

Table 16. Sanofi Monoclonal Antibody Treatment Product and Solutions

Table 17. Sanofi Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Merck Corporate Information, Head Office, and Major Competitors

Table 19. Merck Major Business

Table 20. Merck Monoclonal Antibody Treatment Product and Solutions

Table 21. Merck Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 23. GlaxoSmithKline Major Business

Table 24. GlaxoSmithKline Monoclonal Antibody Treatment Product and Solutions

Table 25. GlaxoSmithKline Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Roche Corporate Information, Head Office, and Major Competitors

Table 27. Roche Major Business

Table 28. Roche Monoclonal Antibody Treatment Product and Solutions

Table 29. Roche Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Novartis Corporate Information, Head Office, and Major Competitors

Table 31. Novartis Major Business

Table 32. Novartis Monoclonal Antibody Treatment Product and Solutions

Table 33. Novartis Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. AbbVie Corporate Information, Head Office, and Major Competitors

Table 35. AbbVie Major Business

Table 36. AbbVie Monoclonal Antibody Treatment Product and Solutions

Table 37. AbbVie Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Shanghai Junshi Biosciences Co.,Ltd Corporate Information, Head Office, and Major Competitors

Table 39. Shanghai Junshi Biosciences Co.,Ltd Major Business

Table 40. Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Product and Solutions

Table 41. Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Innovent Biologics Corporate Information, Head Office, and Major Competitors

Table 43. Innovent Biologics Major Business

Table 44. Innovent Biologics Monoclonal Antibody Treatment Product and Solutions

Table 45. Innovent Biologics Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Jiangsu Hengrui Medicine Co.,Ltd. Corporate Information, Head Office, and Major Competitors

Table 47. Jiangsu Hengrui Medicine Co.,Ltd. Major Business

Table 48. Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Product and Solutions

Table 49. Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. BeiGene, Ltd. Corporate Information, Head Office, and Major Competitors

Table 51. BeiGene, Ltd. Major Business

Table 52. BeiGene, Ltd. Monoclonal Antibody Treatment Product and Solutions

Table 53. BeiGene, Ltd. Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Grand Pharmaceutical (China) Co., Ltd Corporate Information, Head Office, and Major Competitors

Table 55. Grand Pharmaceutical (China) Co., Ltd Major Business

Table 56. Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Product and Solutions

Table 57. Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Henlius Corporate Information, Head Office, and Major Competitors

Table 59. Henlius Major Business

Table 60. Henlius Monoclonal Antibody Treatment Product and Solutions

Table 61. Henlius Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Global Monoclonal Antibody Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 63. Global Monoclonal Antibody Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 64. Breakdown of Monoclonal Antibody Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 65. Monoclonal Antibody Treatment Players Head Office, Products and Services Provided

Table 66. Monoclonal Antibody Treatment Mergers & Acquisitions in the Past Five Years

Table 67. Monoclonal Antibody Treatment New Entrants and Expansion Plans

Table 68. Global Monoclonal Antibody Treatment Revenue (USD Million) by Type (2017-2022)

Table 69. Global Monoclonal Antibody Treatment Revenue Share by Type (2017-2022)

Table 70. Global Monoclonal Antibody Treatment Revenue Forecast by Type (2023-2028)

Table 71. Global Monoclonal Antibody Treatment Revenue by Application (2017-2022)

Table 72. Global Monoclonal Antibody Treatment Revenue Forecast by Application (2023-2028)

Table 73. North America Monoclonal Antibody Treatment Revenue by Type (2017-2022) & (USD Million)

Table 74. North America Monoclonal Antibody Treatment Revenue by Type (2023-2028) & (USD Million)

Table 75. North America Monoclonal Antibody Treatment Revenue by Application (2017-2022) & (USD Million)

Table 76. North America Monoclonal Antibody Treatment Revenue by Application (2023-2028) & (USD Million)

Table 77. North America Monoclonal Antibody Treatment Revenue by Country (2017-2022) & (USD Million)

Table 78. North America Monoclonal Antibody Treatment Revenue by Country (2023-2028) & (USD Million)

Table 79. Europe Monoclonal Antibody Treatment Revenue by Type (2017-2022) & (USD Million)

Table 80. Europe Monoclonal Antibody Treatment Revenue by Type (2023-2028) & (USD Million)

Table 81. Europe Monoclonal Antibody Treatment Revenue by Application (2017-2022) & (USD Million)

Table 82. Europe Monoclonal Antibody Treatment Revenue by Application (2023-2028) & (USD Million)

Table 83. Europe Monoclonal Antibody Treatment Revenue by Country (2017-2022) & (USD Million)

Table 84. Europe Monoclonal Antibody Treatment Revenue by Country (2023-2028) & (USD Million)

Table 85. Asia-Pacific Monoclonal Antibody Treatment Revenue by Type (2017-2022) & (USD Million)

Table 86. Asia-Pacific Monoclonal Antibody Treatment Revenue by Type (2023-2028) & (USD Million)

Table 87. Asia-Pacific Monoclonal Antibody Treatment Revenue by Application (2017-2022) & (USD Million)

Table 88. Asia-Pacific Monoclonal Antibody Treatment Revenue by Application (2023-2028) & (USD Million)

Table 89. Asia-Pacific Monoclonal Antibody Treatment Revenue by Region (2017-2022) & (USD Million)

Table 90. Asia-Pacific Monoclonal Antibody Treatment Revenue by Region (2023-2028) & (USD Million)

Table 91. South America Monoclonal Antibody Treatment Revenue by Type (2017-2022) & (USD Million)

Table 92. South America Monoclonal Antibody Treatment Revenue by Type (2023-2028) & (USD Million)

Table 93. South America Monoclonal Antibody Treatment Revenue by Application (2017-2022) & (USD Million)

Table 94. South America Monoclonal Antibody Treatment Revenue by Application (2023-2028) & (USD Million)

Table 95. South America Monoclonal Antibody Treatment Revenue by Country (2017-2022) & (USD Million)

Table 96. South America Monoclonal Antibody Treatment Revenue by Country (2023-2028) & (USD Million)

Table 97. Middle East & Africa Monoclonal Antibody Treatment Revenue by Type (2017-2022) & (USD Million)

Table 98. Middle East & Africa Monoclonal Antibody Treatment Revenue by Type (2023-2028) & (USD Million)

Table 99. Middle East & Africa Monoclonal Antibody Treatment Revenue by Application (2017-2022) & (USD Million)

Table 100. Middle East & Africa Monoclonal Antibody Treatment Revenue by Application (2023-2028) & (USD Million)

Table 101. Middle East & Africa Monoclonal Antibody Treatment Revenue by Country (2017-2022) & (USD Million)

Table 102. Middle East & Africa Monoclonal Antibody Treatment Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Monoclonal Antibody Treatment Picture

Figure 2. Global Monoclonal Antibody Treatment Revenue Market Share by Type in 2021

Figure 3. Cancer

Figure 4. Autoimmune Diseases

Figure 5. Exogenous Infection

Figure 6. Hematological Diseases

Figure 7. Monoclonal Antibody Treatment Revenue Market Share by Application in 2021

Figure 8. Hospitals Picture

Figure 9. Clinics Picture

Figure 10. Others Picture

Figure 11. Global Monoclonal Antibody Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Monoclonal Antibody Treatment Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Monoclonal Antibody Treatment Revenue Market Share by Region (2017-2028)

Figure 14. Global Monoclonal Antibody Treatment Revenue Market Share by Region in 2021

Figure 15. North America Monoclonal Antibody Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Monoclonal Antibody Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Monoclonal Antibody Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Monoclonal Antibody Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Monoclonal Antibody Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Monoclonal Antibody Treatment Market Drivers

Figure 21. Monoclonal Antibody Treatment Market Restraints

Figure 22. Monoclonal Antibody Treatment Market Trends

Figure 23. Pfizer Recent Developments and Future Plans

Figure 24. Bayer Recent Developments and Future Plans

Figure 25. Sanofi Recent Developments and Future Plans

Figure 26. Merck Recent Developments and Future Plans

Figure 27. GlaxoSmithKline Recent Developments and Future Plans

Figure 28. Roche Recent Developments and Future Plans

Figure 29. Novartis Recent Developments and Future Plans

Figure 30. AbbVie Recent Developments and Future Plans

Figure 31. Shanghai Junshi Biosciences Co.,Ltd Recent Developments and Future Plans

Figure 32. Innovent Biologics Recent Developments and Future Plans

Figure 33. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments and Future Plans

Figure 34. BeiGene, Ltd. Recent Developments and Future Plans

Figure 35. Grand Pharmaceutical (China) Co., Ltd Recent Developments and Future Plans

Figure 36. Henlius Recent Developments and Future Plans

Figure 37. Global Monoclonal Antibody Treatment Revenue Share by Players in 2021

Figure 38. Monoclonal Antibody Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 39. Global Top 3 Players Monoclonal Antibody Treatment Revenue Market Share in 2021

Figure 40. Global Top 10 Players Monoclonal Antibody Treatment Revenue Market Share in 2021

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 42. Global Monoclonal Antibody Treatment Revenue Share by Type in 2021

Figure 43. Global Monoclonal Antibody Treatment Market Share Forecast by Type (2023-2028)

Figure 44. Global Monoclonal Antibody Treatment Revenue Share by Application in 2021

Figure 45. Global Monoclonal Antibody Treatment Market Share Forecast by Application (2023-2028)

Figure 46. North America Monoclonal Antibody Treatment Sales Market Share by Type (2017-2028)

Figure 47. North America Monoclonal Antibody Treatment Sales Market Share by Application (2017-2028)

Figure 48. North America Monoclonal Antibody Treatment Revenue Market Share by Country (2017-2028)

Figure 49. United States Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Canada Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Mexico Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Europe Monoclonal Antibody Treatment Sales Market Share by Type (2017-2028)

Figure 53. Europe Monoclonal Antibody Treatment Sales Market Share by Application (2017-2028)

Figure 54. Europe Monoclonal Antibody Treatment Revenue Market Share by Country (2017-2028)

Figure 55. Germany Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. France Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. United Kingdom Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Russia Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Italy Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Asia-Pacific Monoclonal Antibody Treatment Sales Market Share by Type (2017-2028)

Figure 61. Asia-Pacific Monoclonal Antibody Treatment Sales Market Share by Application (2017-2028)

Figure 62. Asia-Pacific Monoclonal Antibody Treatment Revenue Market Share by Region (2017-2028)

Figure 63. China Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Japan Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South Korea Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. India Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Southeast Asia Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Australia Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South America Monoclonal Antibody Treatment Sales Market Share by Type (2017-2028)

Figure 70. South America Monoclonal Antibody Treatment Sales Market Share by Application (2017-2028)

Figure 71. South America Monoclonal Antibody Treatment Revenue Market Share by Country (2017-2028)

Figure 72. Brazil Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Argentina Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Middle East and Africa Monoclonal Antibody Treatment Sales Market Share by Type (2017-2028)

Figure 75. Middle East and Africa Monoclonal Antibody Treatment Sales Market Share by Application (2017-2028)

Figure 76. Middle East and Africa Monoclonal Antibody Treatment Revenue Market Share by Country (2017-2028)

Figure 77. Turkey Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Saudi Arabia Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. UAE Monoclonal Antibody Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz